Selank

Selank is a synthetic tuftsin analog used off‑label for anxiety reduction, stress relief, and, to a lesser extent, cognitive enhancement and focus. Community users typically dose 500 µg daily, with reported amounts ranging from 100 µg to 10 mg, and most take it each day without a fixed schedule. The main caveat is that the off‑label evidence base is thinner than the discourse suggests, and while serious adverse events are rare, occasional reports mention altered sleep or vivid dreams, with injection‑site reactions not being a consistent theme.

Half-life~18 min

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyClinicalResearchSideEffectsno dataAnecdotalEfficacyAnecdotalSideEffectsPrice1.81.73.42.75.0

Measured on 5 of 6 axes

Research Evidence

Evidence shape

The evidence for Selank is limited, with around 5 human studies, mostly focused on treatment and diagnostic research. These studies cover a few indications, but the overall breadth and quality of the research are constrained by the small number of sponsors and lack of blinded trials with results. The field is also marked by the absence of larger, registered trials, with most research being exploratory or limited in scope.

Depthhow much
0 registered trials
Breadthhow many areas
3 indications mapped
2 thin / exploratory · 1 animal-only · 1 single-trial long-tail
Qualityhow rigorous
No completed trials
Breadth and depth17 rows captured
Human
direct clinical signal
5
Animal
translational support
12
In vitro
mechanistic support
0
HighMediumLow

Anecdotal efficacy

1
US
5151 mg
$59.99
$0.012/mg
2
USA
100 mg
$47.50
$0.47/mg
3
--
50 mg
$60.00
$1.2/mg
4
--
10 mg
$13.99
$1.4/mg
5
--
30 mg
$49.99
$1.67/mg
6
US
100 mg×10
$180.00
$1.8/mg

price offers can be sorted by column

1-6 of 316

Selank dosing & protocol

How Selank is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols · n = 4
Typical dose
0
2 mg
4 mg
6 mg
8 mg
10 mg
no dose captured for this tier yet
Frequency
not extractable from trial records
Route
intranasal

The four human studies listed used intranasal Selank, but the trial records did not provide a clear dose, frequency, or cycling schedule. Consequently, no reliable milligram amount or regimen can be summarized for this tier.

4 sources
Clinician practice
Doctor & published-protocol guidance
Typical dose
0
2 mg
4 mg
6 mg
8 mg
10 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Anecdotal
Community-reported real-world use · n = 31
Typical dose
500 µg100 µg – 10 mg
typical
0
2 mg
4 mg
6 mg
8 mg
10 mg
distribution of 37 reported doses · darker = more
By reported cadence· tap a row to filter the chart
By stated route· tap a row to filter the chart
Frequency
mostly daily
Route
intranasal

Most users who specified a schedule take about 500 mcg intranasally each day, while a smaller group dose weekly around 250 mcg; many reports give no set frequency.

31 sources